Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C
Medicaid prior authorization (PA) policies for treatment of hepatitis C virus (HCV) with direct‐acting antiviral (DAA) therapy are changing. We aimed to evaluate effects of changes in PA requirements on treatment uptake and to determine the factors associated with DAA treatment among Florida Medicai...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Health/LWW
2021-02-01
|
| Серія: | Hepatology Communications |
| Онлайн доступ: | https://doi.org/10.1002/hep4.1634 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|